Recent filings on October 30, 2025, revealed varied activity among institutional investors regarding Alibaba's stock. While GWN Securities Inc. significantly decreased its holdings by 96.4%, other institutions like Y Intercept Hong Kong Ltd increased their stake by 197%. Additionally, Migdal Insurance & Financial Holdings Ltd. added 279,600 shares to its portfolio. Despite the mixed institutional sentiment, analyst ratings remain largely positive. The consensus rating for Alibaba is a "Moderate Buy," with a consensus price target of $190.18. Recent price targets from analysts in October include estimates as high as $240 from JP Morgan and $200 from Bernstein, suggesting continued confidence in the company's performance.